HOME > TOP STORIES
TOP STORIES
-
BUSINESS Maruho Aspires to Get Back on Growth Track on New Drug Launches: President
April 12, 2021
-
BUSINESS Kobayashi Kako’s Seima Factory Operations Still Halted Even after 60-Day Order Lifted
April 12, 2021
-
ORGANIZATION Wakayama Council Makes List of 500 Drugs Commonly Used in Region, Snubs Nichi-Iko/Kobayashi Kako Generics
April 9, 2021
-
BUSINESS Nichi-Iko Recalls 2 Products over Quality Issues Days after Biz Suspension Lifted
April 9, 2021
-
BUSINESS Teijin Pharma Set to Transform Biz, Weather Feburic Patent Cliff with Takeda’s DPP-4s
April 8, 2021
-
BUSINESS Astellas Ended Scholarship Donation to Clear Up Doubts on Inducing Prescriptions, No Major Issues Seen after 1 Year
April 8, 2021
-
BUSINESS Takeda Sees FY2021 as Inflection Year for Pipeline, 4 Potential Approvals from 6 Submission-Planned Assets
April 7, 2021
-
BUSINESS AstraZeneca Looks to Become Top Drug Maker in Japan by 2025
April 7, 2021
-
REGULATORY AMED to Set Up Council to Hone Academic Seeds with Industry Input
April 7, 2021
-
BUSINESS Daiichi Sankyo Looks to Rack Up Sales of 1.6 Trillion Yen in FY2025, 3 ADCs as Drivers
April 6, 2021
-
REGULATORY MHLW to Consider Ways to Address Listing Delays Linked to Off-Year Re-Pricing: Official
April 6, 2021
-
REGULATORY Nichi-Iko’s Toyama Plant Gets Back Online as Suspension Order Lifted
April 6, 2021
-
REGULATORY Ex-PMDA Inspector Urges Improvements in Japanese Inspection Systems after GMP Scandals
April 5, 2021
-
BUSINESS Takeda/CSL-Led Alliance’s COVID-19 Plasma Therapy Fails in PIII
April 5, 2021
-
BUSINESS GSK Sees Promise in Antibody Therapy against Coronavirus Variants, Looking at Japan Rollout Too
April 2, 2021
-
BUSINESS Alinamin Aims for Growth via Retail Promotion, Full Entry into Asia: President
April 2, 2021
-
BUSINESS Sandoz Shooting for Top Foreign Player in Japan Generic Market by 2023
April 1, 2021
-
BUSINESS Japan Trials Get Underway for AstraZeneca’s COVID-19 Antibody Therapy
April 1, 2021
-
ORGANIZATION Generic Industry Group Requests Blanket Manufacturing Checkups for 39 Member Firms
March 31, 2021
-
BUSINESS Nafamostat Inhalation Drug Now in Clinic for COVID-19: Daiichi Sankyo
March 31, 2021
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
